PROCEPT BioRobotics (PRCT) Debt to Equity (2020 - 2025)
PROCEPT BioRobotics (PRCT) has disclosed Debt to Equity for 6 consecutive years, with $0.14 as the latest value for Q4 2025.
- On a quarterly basis, Debt to Equity rose 6.12% to $0.14 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.14, a 6.12% increase, with the full-year FY2025 number at $0.14, up 6.12% from a year prior.
- Debt to Equity was $0.14 for Q4 2025 at PROCEPT BioRobotics, up from $0.14 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.33 in Q2 2023 to a low of $0.13 in Q4 2024.
- A 5-year average of $0.2 and a median of $0.19 in 2022 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: surged 169.94% in 2021, then tumbled 38.79% in 2025.
- PROCEPT BioRobotics' Debt to Equity stood at $0.19 in 2021, then soared by 38.81% to $0.26 in 2022, then dropped by 27.05% to $0.19 in 2023, then dropped by 29.88% to $0.13 in 2024, then increased by 6.12% to $0.14 in 2025.
- Per Business Quant, the three most recent readings for PRCT's Debt to Equity are $0.14 (Q4 2025), $0.14 (Q3 2025), and $0.13 (Q2 2025).